Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Diagn Pathol ; 19(1): 111, 2024 Aug 16.
Article in English | MEDLINE | ID: mdl-39148135

ABSTRACT

BACKGROUND: Lennert lymphoma (LL) is a variant of peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS), also known as a lymphoepithelioid variant of PTCL. Because of the rarity and lack of clear-cut diagnostic criteria, LL is susceptible tomisdiagnosis. Although previously diagnosed with LL might be reclassified and evaluated with the advent of of molecular and/or genetic findings, cytomorphology and immunohistochemistry are still the key to give rise to correct diagnosis. CASE PRESENTATION: We report a case of a patient who was diagnosed as LL based on cytomorphology and immunohistochemistry. Routine stain (Hematoxlin and Eosin-H&E) revealed tumor cells were mainly small to medium-sized CD4(+) T cells, the CD8 +/TIA-1 + cytotoxic cells were less minority, no expressions of follicle helper T cell markers (CD10, BCL6, PD1, CXCL13, ICOS) or CD21(+) hyperplastic FDC network, or proliferation of high edndothelial venules were noted; however, numerous epithelioid histiocytes are noted in the background and scattered EBV(+) cells were also present. The patient was achieved complete remission after six courses of chemotherapy with cyclophosphamide, epirubicin, vincristine, etoposide, and prednisone regimen. She was followed for 5 years without recurrence or progression. CONCLUSIONS: Classic LL is not difficult to diagnose by cytomorphology and immunohistochemistry, and the mutation profiles can be helpful to distinguish LL from other lymphomas.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols , Biomarkers, Tumor , Immunohistochemistry , Lymphoma, T-Cell, Peripheral , Humans , Biomarkers, Tumor/analysis , Lymphoma, T-Cell, Peripheral/pathology , Lymphoma, T-Cell, Peripheral/diagnosis , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Female , Middle Aged , Treatment Outcome , Predictive Value of Tests
2.
J Int Med Res ; 52(3): 3000605241233972, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38488658

ABSTRACT

Light chain deposition disease (LCDD) is an under-recognized condition characterized by deposition of abnormal monoclonal light chains in tissues, leading to organ dysfunction. LCDD involving the gastrointestinal tract is very uncommon, and its diagnosis is challenging. We herein report two cases of LCDD that manifested as inflammatory bowel disease-like symptoms and protein-losing gastroenteropathy. Both patients were women in their early 60s. Tissue biopsies from the gastrointestinal mucosa demonstrated extracellular deposits, which were negative by Congo red staining but positive for κ-light chain by immunohistochemistry. The recent literature on LCDD was reviewed. When patients unexpectedly show extracellular deposits in gastrointestinal biopsy specimens, evaluation of immunoglobulin chains is recommended for diagnosis of LCDD after systemic amyloidosis has been excluded.


Subject(s)
Amyloidosis , Gastrointestinal Diseases , Multiple Myeloma , Humans , Female , Male , Immunoglobulin Light Chains , Immunoglobulin kappa-Chains , Amyloidosis/pathology , Gastrointestinal Diseases/complications , Gastrointestinal Diseases/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL